C12R 1 - Micro-organisms - Patents Sitemap

Patents for C12R 1 - Micro-organisms (92,025)
12/1992
12/23/1992	EP0519016A1 Method for diagnosis of lyme disease
12/23/1992	EP0519001A1 PURIFIED gp120 COMPOSITION RETAINING NATURAL CONFORMATION
12/23/1992	EP0518999A1 Protein hydrolysates.
12/23/1992	EP0518902A1 Pharmaceuticals
12/23/1992	EP0262192B1 Method and means for producing a protein having the same igg specificity as protein g
12/23/1992	CN1067268A Rapidly hydrating welan gum
12/23/1992	CA2111672A1 Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis
12/23/1992	CA2111217A1 Insertional mutations in mycobacteria
12/23/1992	CA2111110A1 Production and recovery of recombinant neurotrophins
12/23/1992	CA2111108A1 Hepatitis c diagnostics and vaccines
12/23/1992	CA2110799A1 Microbially-produced antibody fragments and their conjugates
12/22/1992	US5173420 Monoclonal antibody recognizing un-natural ganglioside gd3
12/22/1992	US5173419 Purified chitinases and use thereof
12/22/1992	US5173417 For hydrolyzing triglycerides to glycerol and fatty acids
12/22/1992	US5173416 L-carnitine dehydrogenase from alcalgenes
12/22/1992	US5173414 Production of recombinant adeno-associated virus vectors
12/22/1992	US5173412 Microbiological process for the production of hydroxylated pyrazine derivatives
12/22/1992	US5173403 Thermostable acid protease from sulfolobus acidocaldarius and gene
12/22/1992	US5173399 Mouse monoclonal antibodies to hiv-1p24 and their use in diagnostic tests
12/22/1992	US5173297 Bacteriocin from lactococcus lactis subspecies lactis
12/22/1992	US5173294 Purified antiserum which recognizes homophilus influenzae outer membrane protein for treating diseases caused by pathogen
12/22/1992	CA2071622A1 Anti-tcf-ii monoclonal antibodies and method for the measurement of tcf-ii by applying the antibodies
12/22/1992	CA2069596A1 Microbiological process for the production of 5-hydroxypyrazinecarboxylic acid
12/22/1992	CA1311704C Substantially purified tumor growth inhibitory factor (tif)
12/22/1992	CA1311703C Culture medium of bacteria (bordetella genum) containing etherified derivatives of d-glucose, and their application
12/20/1992	CA2071066A1 Fk-900520 enzymatic and/or microbial methylation products
12/19/1992	CA2071395A1 Coccidiosis poultry vaccine
12/19/1992	CA2071305A1 Anti-hiv antibodies
12/19/1992	CA2065919A1 Leydig cell stimulator
12/16/1992	EP0518757A1 Peptides or polypeptides of BVD and related viruses
12/16/1992	EP0518756A1 Procedure to detect a bovine viral diarrhoea virus infection, nucleotide sequence coding for a protein induced by infection with this virus and recombinant proteins and antigens resulting from same
12/16/1992	EP0518587A2 A-C-B proinsulin, method of manufacturing and using same, and intermediates in insulin production
12/16/1992	EP0518443A1 Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
12/16/1992	EP0518136A2 Fermentation process for producing 2-keto-L-gulonic acid
12/16/1992	EP0518096A1 Yogurt containing living microorganisms
12/16/1992	EP0518088A2 Process for clostripain-catalysed coupling of Arg-Pro and Arg-B (B=proteinogenic or non proteinogenic amino acids) containing them
12/16/1992	EP0517925A1 Novel megakaryocyte amplifier and production thereof
12/16/1992	EP0517854A1 Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis
12/16/1992	EP0517829A1 Improved chimeric toxins
12/16/1992	EP0517826A1 CLONING AND PRODUCTION OF HUMAN VON WILLEBRAND FACTOR GPIb BINDING DOMAIN POLYPEPTIDES AND METHODS OF USING SAME
12/16/1992	EP0517815A1 AN IgG-1 HUMAN MONOCLONAL ANTIBODY REACTIVE WITH AN HIV-1 GLYCOPROTEIN AND METHOD OF USE
12/16/1992	EP0517779A1 SUBSTANTIALLY PURE TRANSFORMING GROWTH FACTOR-$g(b)1-BINDING PROTEIN AND NUCLEOTIDE SEQUENCES EXPRESSING THE BINDING PROTEIN
12/16/1992	EP0517754A1 Antibody constructs with enhanced binding affinity
12/16/1992	EP0299028B1 Process for producing l-aminoacids
12/16/1992	CN1066959A Improved process for preparing coated microbial pesticides and pesticides producted therefrom
12/15/1992	US5171844 For use in treating hemophilia
12/15/1992	US5171841 T-cell suppressor protein
12/15/1992	US5171840 Receptor protein for human B cell stimulatory factor-2
12/15/1992	US5171839 Nucleotide and amino acid sequences of protein mtp40 of m. tuberculosis and synthetic peptides derived therefrom
12/15/1992	US5171836 Bactericides for use aganist methicillin-resistant bacteria
12/15/1992	US5171739 Treatment of endotoxin-associated shock and preventation thereof using a BPI protein
12/15/1992	US5171684 Bioconversions catalyzed by the toluene monooxygenase of Pseudomanas mendocina KR-1
12/15/1992	US5171681 Useful for producing carboxylic acid from corresponding alcohol and aldehyde
12/15/1992	US5171677 Recombinant marek's disease virus and process for preparing the same
12/15/1992	US5171673 Genetic engineering to produce a desired heterologous polypeptides in gram positive bacteria
12/15/1992	US5171670 Recombinant dna method for production of parathyroid hormone
12/15/1992	US5171666 Monoclonal antibodies reactive with a cell-surface gylcoprotein expressed on human carcinomas
12/15/1992	US5171665 Monoclonal antibody to novel antigen associated with human tumors
12/15/1992	CA2071143A1 Squalene synthetase inhibitors and processes therefrom
12/15/1992	CA1311433C Method for supressing weed grasses using xanthomonas campestris
12/15/1992	CA1311431C Carbomycin biosynthetic gene, designated carg, for use in streptomycesand other organisms
12/15/1992	CA1311430C Construction of an igg binding protein to facilitate downstream processing using protein engineering
12/14/1992	WO1992001062A1 Process for producing enantiomers of 2-aryl-alkanoic acids
12/12/1992	WO1992022654A1 Vaccine and treatment method of human immunodeficiency virus infection
12/12/1992	WO1992022642A1 Universal site-specific nucleases
12/12/1992	CA2108134A1 Universal site-specific nucleases
12/12/1992	CA2087732A1 Vaccine and treatment method of human immunodeficiency virus infection
12/12/1992	CA2071015A1 Immunogenic peptides or polypeptides of the bvd virus and related viruses, vaccines incorporating them or expressing them, methods and means of production thereof
12/10/1992	WO1992021766A1 Monoclonal antibodies against c-kit
12/10/1992	WO1992021763A1 Enhancement of expression by gene targeting in endogenous retrovirus-like sequences
12/10/1992	WO1992021760A1 Mutant proteolytic enzymes from bacillus
12/10/1992	WO1992021758A1 Mycobacterium proteins and applications
12/10/1992	WO1992021756A1 Methods and compositions relating to genetically engineered cells that produce insulin in response to glucose
12/10/1992	WO1992021754A1 Dna which codes for secretin receptor and polypeptide which is coded for by said dna
12/10/1992	WO1992021749A1 Trace element-rich additive, method for preparing same, preparation in which the additive is included and use thereof
12/10/1992	WO1992021248A1 Method for production of a whey protein hydrolyzate
12/10/1992	WO1992021246A1 Food additive for human and animal foodstuffs and foodstuffs containing same
12/10/1992	WO1992021240A1 Suppressor t-cell hybridoma
12/10/1992	WO1992019700A3 Continuous process for biocatalytic desulfurization of sulfur-bearing heterocyclic molecules
12/10/1992	WO1992014818A3 Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences
12/10/1992	CA2110389A1 Mycobacterium proteins and applications
12/10/1992	CA2110256A1 Trace element-rich additive, method for preparing same, preparation in which the additive is included and use thereof
12/10/1992	CA2103365A1 Methods and compositions relating to genetically engineered cells that produce insulin in response to glucose
12/10/1992	CA2103046A1 Suppressor t-cell hybridoma
12/09/1992	EP0517484A2 Fermentation analogs of virginiamycin M1
12/09/1992	EP0517413A1 Fermentation of a triol heptanoic acid by mutant strains of aspergillus terreus
12/09/1992	EP0517394A1 A prophylactic/therapeutic composition for swine pleuropneumonia
12/09/1992	EP0517292A1 Recombinant Avipox virus
12/09/1992	EP0517200A2 Process for the enzymatic production of cephalosporane derivatives
12/09/1992	EP0517111A1 A novel type II restriction endonuclease, PmeI, obtainable from pseudomonas mendocina and a process for producing the same
12/09/1992	EP0517024A2 Tetravalent bispecific receptors, their preparation and use
12/09/1992	EP0516958A2 Caffeoyl-coA-3-O-methyltransferase gene
12/09/1992	EP0516787A1 Expression systems
12/09/1992	EP0516721A1 Antigenic proteins of plasmodium
12/09/1992	EP0516655A1 Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine.
12/09/1992	EP0516647A1 Polypeptides involved in the biosynthesis of cobalamines and/or cobamides, dna sequences coding for these polypeptides, and their preparation and use
12/09/1992	CN1019355B Process for minactivin and its use
12/08/1992	US5169941 DNA sequences coding for the DR β-chain locus of the human lymphocyte antigen complex and polypeptides, diagnostic typing processes and products related thereto
12/08/1992	US5169930 Integrin with preferential binding to fibronectin not vitronectin
12/08/1992	US5169840 Diequatorially bound β-1, 4 polyuronates and use of same for cytokine stimulation

1 ... 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 ... 921